• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中的神经认知障碍及其对治疗选择的影响。

Neurocognitive impairment in schizophrenia and how it affects treatment options.

作者信息

Bilder R M

机构信息

Hillside Hospital Division of Long Island Jewish Medical Center, Glen Oaks, New York.

出版信息

Can J Psychiatry. 1997 Apr;42(3):255-64. doi: 10.1177/070674379704200303.

DOI:10.1177/070674379704200303
PMID:9114941
Abstract

OBJECTIVE

To review the roles played by neurocognitive assessment in the treatment of schizophrenia and in the design of treatment research strategies.

METHOD

A review of the literature and summaries of clinical and research implications are presented, with directions for future research.

RESULTS

Neurocognitive deficits are now targets of antipsychotic drug treatment and should increasingly be used to refine both theory and clinical practice by considering the effects of treatments at the level of neural systems.

CONCLUSION

Efforts to bridge the gaps between preclinical and clinical assessments should yield large rewards in drug development and individualized treatment strategies. Functional neuroimaging may play a major role in these developments.

摘要

目的

回顾神经认知评估在精神分裂症治疗及治疗研究策略设计中所起的作用。

方法

对文献进行综述,并呈现临床及研究意义总结以及未来研究方向。

结果

神经认知缺陷现已成为抗精神病药物治疗的靶点,通过考虑治疗在神经系统层面的作用,应越来越多地用于完善理论和临床实践。

结论

弥合临床前评估与临床评估之间差距的努力,有望在药物研发和个体化治疗策略方面带来巨大回报。功能神经影像学可能在这些进展中发挥重要作用。

相似文献

1
Neurocognitive impairment in schizophrenia and how it affects treatment options.精神分裂症中的神经认知障碍及其对治疗选择的影响。
Can J Psychiatry. 1997 Apr;42(3):255-64. doi: 10.1177/070674379704200303.
2
Cognitive neuroscience and schizophrenia: translational research in need of a translator.认知神经科学与精神分裂症:亟需译者的转化研究。
Biol Psychiatry. 2008 Jul 1;64(1):2-3. doi: 10.1016/j.biopsych.2008.04.031.
3
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.非典型抗精神病药物对精神分裂症神经认知障碍的影响:一项综述与荟萃分析
Schizophr Bull. 1999;25(2):201-22. doi: 10.1093/oxfordjournals.schbul.a033374.
4
The neurobiology of cognition in schizophrenia.精神分裂症认知的神经生物学
J Clin Psychiatry. 2006 Sep;67(9):e11.
5
The neurobiology of cognition in schizophrenia.精神分裂症认知的神经生物学
J Clin Psychiatry. 2006;67 Suppl 9:9-13; discussion 36-42.
6
The role of limbic and cortical regions in schizophrenia: focus on dopamine.边缘和皮质区域在精神分裂症中的作用:聚焦于多巴胺。
Eur Psychiatry. 2002 Aug;17 Suppl 4:349s-354s. doi: 10.1016/s0924-9338(03)00078-6.
7
Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.抗精神病药物治疗引起的认知改善:CATIE试验中抗精神病药物对慢性精神分裂症患者的神经认知影响
Arch Gen Psychiatry. 2007 Jun;64(6):631-2. doi: 10.1001/archpsyc.64.6.631.
8
Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.精神分裂症中的认知功能障碍及其对预后的重要性:非典型抗精神病药物在治疗中的地位。
J Clin Psychiatry. 1999;60 Suppl 23:25-8.
9
Executive functioning component mechanisms and schizophrenia.执行功能组成机制与精神分裂症。
Biol Psychiatry. 2008 Jul 1;64(1):26-33. doi: 10.1016/j.biopsych.2008.04.027.
10
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.精神分裂症患者的抗精神病药物治疗。作用机制及临床意义。
Br J Psychiatry Suppl. 1994 Apr(23):65-70.

引用本文的文献

1
COMT Val158Met polymorphism influences the susceptibility to framing in decision-making: OFC-amygdala functional connectivity as a mediator.儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性影响决策框架效应易感性:以眶额叶皮质-杏仁核功能连接作为中介因素
Hum Brain Mapp. 2016 May;37(5):1880-92. doi: 10.1002/hbm.23142. Epub 2016 Feb 25.
2
Do patterns of mental healthcare predict treatment failure in young people with schizophrenia? Evidence from an Italian population-based cohort study.精神卫生保健模式能否预测精神分裂症青少年的治疗失败?来自一项意大利基于人群的队列研究的证据。
BMJ Open. 2015 Jun 3;5(6):e007140. doi: 10.1136/bmjopen-2014-007140.
3
Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia.
男性精神分裂症患者首发期血清硫酸脱氢表雄酮升高而非后续发作期。
Neuropsychiatr Dis Treat. 2014 Apr 29;10:687-93. doi: 10.2147/NDT.S61406. eCollection 2014.
4
Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments.精神分裂症谱系障碍的当前治疗方法,第一部分:概述与药物治疗。
Neuropsychiatr Dis Treat. 2013;9:1311-32. doi: 10.2147/NDT.S37485. Epub 2013 Sep 11.
5
Executive control: balancing stability and flexibility via the duality of evolutionary neuroanatomical trends.执行控制:通过进化神经解剖学趋势的二元性平衡稳定性和灵活性。
Dialogues Clin Neurosci. 2012 Mar;14(1):39-47. doi: 10.31887/DCNS.2012.14.1/rbilder.
6
Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.抑制大脑型 1 cannabinoid 受体与氯胺酮诱导的精神分裂症模型中听觉失配负波产生受损有关。
Psychopharmacology (Berl). 2011 Dec;218(4):611-20. doi: 10.1007/s00213-011-2352-y. Epub 2011 May 18.
7
Pharmacotherapy for treatment-resistant schizophrenia.治疗抵抗性精神分裂症的药物治疗。
Neuropsychiatr Dis Treat. 2011;7:135-49. doi: 10.2147/NDT.S12769. Epub 2011 Mar 17.
8
Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns.首发精神分裂症谱系障碍早期病程中的认知功能:时间与模式
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):364-71. doi: 10.1007/s00406-006-0646-6. Epub 2006 Jun 20.
9
Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.精神分裂症中的功能失调连接与运动功能的注意力调节相关。
Brain. 2005 Nov;128(Pt 11):2597-611. doi: 10.1093/brain/awh632. Epub 2005 Sep 23.
10
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.喹硫平或氟哌啶醇治疗后精神分裂症患者的神经心理学变化。
J Psychiatry Neurosci. 2001 Mar;26(2):137-49.